Related Experiment Video
Updated: Aug 7, 2026

10:39
3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache
Published on: June 2, 2014
CSF-endorphines in acute and chronic brain lesions
1Department of Neurosurgery Klinikum Ingolstadt, West Germany.
Neurosurgical Review
|January 1, 1988
Summary
Beta-endorphin (beta-END) and beta-lipotropic hormone (beta-LPH) levels in cerebrospinal fluid (CSF) correlate with consciousness. Lower beta-END CSF levels are associated with decreased consciousness and coma.
Area of Science:
- Neuroscience
- Endocrinology
- Biochemistry
Background:
- Opioid peptides like beta-endorphin play roles in the central nervous system.
- Understanding the relationship between endogenous opioids and consciousness is crucial for neurological research.
Purpose of the Study:
- To investigate the influence of opioid peptides, specifically beta-endorphin (beta-END) and beta-lipotropic hormone (beta-LPH), on human consciousness.
- To quantify beta-END and beta-LPH levels in cerebrospinal fluid (CSF) and blood plasma of neurosurgical patients.
Main Methods:
- Radio-immunoassay was used to measure beta-END and beta-LPH levels.
- Samples were collected from ventricular CSF and blood plasma of 101 neurosurgical patients.
- Data analysis considered factors like sex, age, time of day, consciousness level, blood pressure, and disease type.
Main Results:
- Beta-END and beta-LPH levels were lower in CSF compared to blood plasma.
- CSF beta-END levels decreased with age and showed diurnal variations.
- A significant correlation was observed between lower CSF beta-END levels and reduced consciousness or comatous states.
- CSF beta-END levels increased with higher systolic arterial blood pressure.
Conclusions:
- Opioid peptide levels in CSF, particularly beta-END, are linked to the state of consciousness.
- These findings suggest a potential role for endogenous opioids in modulating consciousness in neurological conditions.
More Related Videos
Related Concept Videos
Acute Inflammation III: Local and Systemic Effects
Acute inflammation produces a coordinated set of local and systemic changes that limit injury, eliminate pathogens, and initiate repair. These responses arise within minutes of infection, trauma, or chemical insult and are driven by vascular alterations and leukocyte-derived mediators. When the stimulus resolves, the reaction typically abates within days.Local EffectsAt the site of injury, arteriolar vasodilation increases blood flow, resulting in redness and warmth. Simultaneously, increased...
Cerebral Edema ll: Pathophysiology
Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this barrier loses...
Cytotoxic Edema: Pathophysiology
Cytotoxic edema is a form of cerebral edema characterized by intracellular swelling of neurons, astrocytes, and other glial cells. It develops when the mechanisms responsible for maintaining ionic gradients across the cell membrane become impaired. Under normal physiological conditions, the sodium–potassium ATPase actively transports sodium ions out of the cell and potassium ions into the cell, preserving osmotic balance and enabling electrical signaling. This pump requires a continuous supply...

